Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-11-04 Sale | 2026-11-04 5:05 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,769 | $15.63 | $74,562 | 42,745 (Direct) | View |
| 2026-11-02 Sale | 2026-11-04 5:03 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 16,715 | $25.84 | $431,904 | 109,871 (Direct) | View |
| 2026-10-30 Sale | 2026-11-02 7:47 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,834 | $26.28 | $74,475 | 107,894 (Direct) | View |
| 2026-10-30 Sale | 2026-11-02 7:44 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,957 | $26.28 | $103,986 | 75,715 (Direct) | View |
| 2026-10-30 Sale | 2026-11-02 7:42 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,409 | $26.42 | $142,900 | 241,786 (Direct) | View |
| 2026-10-15 Sale | 2026-10-15 5:00 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $25 | $36,300 | 176,633 (Direct) | View |
| 2026-10-14 Sale | 2026-10-14 4:11 pm | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 22,583 | $23.4 | $528,528 | 10,750 (Direct) | View |
| 2026-10-02 Sale | 2026-10-02 5:21 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,786 | $23.19 | $134,149 | 120,361 (Direct) | View |
| 2026-09-02 Sale | 2026-09-02 7:42 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $25.76 | $149,072 | 126,147 (Direct) | View |
| 2026-09-01 Sale | 2026-09-01 5:19 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $25.47 | $36,982 | 178,085 (Direct) | View |
| 2026-08-05 Sale | 2026-08-05 6:59 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $25 | $108,900 | 179,537 (Direct) | View |
| 2026-08-04 Sale | 2026-08-05 06:39 am | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,111 | $24.36 | $100,142 | 117,227 (Direct) | View |
| 2026-08-04 Sale | 2026-08-04 9:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,761 | $24.36 | $115,989 | 40,166 (Direct) | View |
| 2026-08-03 Sale | 2026-08-03 5:51 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 16,589 | $23.05 | $382,358 | 131,934 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:58 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,845 | $23.38 | $66,524 | 115,489 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:56 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,847 | $23.38 | $89,954 | 90,474 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:50 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,847 | $23.38 | $89,954 | 191,900 (Direct) | View |
| 2026-07-02 Sale | 2026-07-02 6:02 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 11,008 | $23.56 | $259,366 | 142,190 (Direct) | View |
| 2026-06-25 Sale | 2026-06-25 6:49 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,394 | $20 | $107,880 | 115,005 (Direct) | View |
| 2026-06-25 Sale | 2026-06-25 6:38 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 28,935 | $20.06 | $580,506 | 147,977 (Direct) | View |
| 2026-06-02 Sale | 2026-06-02 7:14 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $16.6 | $135,253 | 18,800 (Direct) | View |
| 2026-05-05 Sale | 2026-05-05 7:53 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 14,055 | $16.6 | $233,319 | 37,592 (Direct) | View |
| 2026-05-04 Sale | 2026-05-04 6:10 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $16.96 | $138,210 | 18,305 (Direct) | View |
| 2026-05-01 Sale | 2026-05-01 5:50 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,394 | $16.76 | $90,407 | 26,453 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:38 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,388 | $16.65 | $39,749 | 89,514 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:37 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,214 | $16.65 | $53,498 | 69,714 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:35 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,214 | $16.65 | $53,498 | 158,266 (Direct) | View |
| 2026-04-02 Sale | 2026-04-02 7:02 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $15.24 | $124,149 | 26,453 (Direct) | View |
| 2026-03-02 Sale | 2026-03-02 7:05 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $15.44 | $125,793 | 34,601 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-02 Exercise | 2026-11-04 5:03 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,786 | $8.72 | 109,871 (Direct) | View |
| 2026-11-02 Exercise | 2026-11-04 5:03 pm | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,786 | $0 | 109,871 (Direct) | View |
| 2026-10-30 Exercise | 2026-11-02 7:47 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 10,182 | $0 | 107,894 (Direct) | View |
| 2026-10-30 Exercise | 2026-11-02 7:44 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,182 | $0 | 75,715 (Direct) | View |
| 2026-10-30 Exercise | 2026-11-02 7:42 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 11,634 | $0 | 241,786 (Direct) | View |
| 2026-11-02 Exercise | 2026-11-02 7:42 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $1.86 | 241,786 (Direct) | View |
| 2026-10-15 Exercise | 2026-10-15 5:00 pm | N/A 2029-08-28 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $0 | 176,633 (Direct) | View |
| 2026-10-15 Exercise | 2026-10-15 5:00 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $1.86 | 176,633 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-14 4:11 pm | N/A 2029-12-22 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 22,583 | $0 | 10,750 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-14 4:11 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 22,583 | $1.86 | 10,750 (Direct) | View |
| 2026-10-02 Exercise | 2026-10-02 5:21 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,786 | $8.72 | 120,361 (Direct) | View |
| 2026-10-02 Exercise | 2026-10-02 5:21 pm | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,786 | $0 | 120,361 (Direct) | View |
| 2026-09-02 Exercise | 2026-09-02 7:42 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $8.72 | 126,147 (Direct) | View |
| 2026-09-02 Exercise | 2026-09-02 7:42 pm | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $0 | 126,147 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-01 5:19 pm | N/A 2029-08-28 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $0 | 178,085 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-01 5:19 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 1,452 | $1.86 | 178,085 (Direct) | View |
| 2026-08-05 Exercise | 2026-08-05 6:59 pm | N/A 2029-08-28 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $0 | 179,537 (Direct) | View |
| 2026-08-05 Exercise | 2026-08-05 6:59 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $1.86 | 179,537 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 5:51 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $8.72 | 131,934 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 5:51 pm | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $0 | 131,934 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:58 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 10,180 | $0 | 115,489 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:56 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,180 | $0 | 90,474 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:50 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 10,180 | $0 | 191,900 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $8.72 | 142,190 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 11,008 | $0 | 142,190 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,221 | $1.86 | 142,190 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 13,333 | $7.26 | 147,977 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 15,602 | $8.72 | 147,977 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A 2030-02-26 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 28,935 | $0 | 147,977 (Direct) | View |
| 2026-06-02 Exercise | 2026-06-02 7:14 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,422 | $0 | 18,800 (Direct) | View |
| 2026-06-02 Exercise | 2026-06-02 7:14 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,422 | $1.86 | 18,800 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:56 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:55 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:52 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:51 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:49 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:46 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | DANSEY ROGER D Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:42 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:37 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,608 | $0 | 89,514 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:37 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,608 | $0 | 69,714 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,608 | $0 | 158,266 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 6:09 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:55 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:50 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 136,625 | $0 | 136,625 (Direct) | View |